Percentage of medical schools including specific topic in curriculum (non-respondents classified as “not stated”) and percentage of pre-registration house officer (PRHO) respondents recalling teaching on specific topic
| Specific topics covered in questionnaire sent to medical school deans and PRHOs | Percentage of medical schools who report including topic in undergraduate curriculum | Percentage of PRHO respondents who recalled teaching on topic in undergraduate curriculum | ||||||
|---|---|---|---|---|---|---|---|---|
| Required (part of compulsory curriculum) | Optional (part of elective or special study module) | Not taught | Not stated (no response or “don’t know “) | Required (part of compulsory curriculum) | Optional (part of elective or special study module) | Not taught | Not stated (no response or “can’t remember”) | |
| Cancer risk | 88 | − | − | 12 | 97 | 1 | 1 | 1 |
| Other health effects | 84 | − | − | 16 | 90 | 3 | 6 | 1 |
| Passive smoking | 80 | − | − | 20 | 53 | 9 | 37 | 1 |
| Determinants of smoking | 64 | 8 | 8 | 20 | 42 | 9 | 47 | 2 |
| Contents of cigarette smoke | 68 | 4 | 8 | 20 | 45 | 9 | 45 | 1 |
| Pharmacology of nicotine addiction | 60 | 4 | 8 | 28 | 28 | 12 | 59 | 1 |
| Nicotine withdrawal symptoms | 56 | 8 | 8 | 28 | 43 | 11 | 45 | 1 |
| High risk groups | 68 | 8 | 8 | 16 | 66 | 8 | 25 | 1 |
| Population strategies | 68 | 8 | 8 | 16 | 48 | 14 | 37 | 1 |
| Nicotine replacement therapy | 52 | 16 | 8 | 24 | 48 | 17 | 34 | 1 |
| Other pharmacological agents | 36 | 20 | 12 | 32 | 25 | 15 | 59 | 1 |
| Clinical interventions: the 5 A’s | 52 | 20 | 8 | 20 | 28 | 12 | 59 | 1 |
| Practical delivery in artificial settings, e.g. role play | 28 | 8 | 40 | 24 | 20 | 10 | 69 | 1 |
| Practical delivery in clinical settings | 24 | 12 | 40 | 24 | 17 | 15 | 67 | 1 |
| Practical delivery in clinical settings with evaluation | 8 | 24 | 44 | 24 | 8 | 10 | 81 | 1 |